Results for “Nairn Academy”

The US FDA has flagged a potential risk of a rare condition called eye stroke linked to GLP-1 medications, including Ozempic, Wegovy and Mounjaro. The condition can cause sudden, painless and potentially permanent...

These drugs may be associated with a drop in blood flow to the optic nerve which can cause sudden, painless loss of vision in one eye, and sometimes the damage is permanent, FDA said

GLP-1 drugs will now carry a warning for a rare, but potentially dangerous side effect that can lead to vision loss, the FDA says. Dr. Rachel Pessah-Pollack joins CBS News to discuss.

The FDA is requiring new safety warnings for popular GLP-1 weight-loss medications over a potential increased risk of a rare eye condition that can cause sudden vision loss.